BioGaia AB
Clinical trials sponsored by BioGaia AB, explained in plain language.
A biotech company developing probiotic products for health and nutrition.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could probiotic cream soothe Children's dry skin? Results expected Feb 2027 (estimated)
-
Can a probiotic stop UTIs from coming back?
Disease control CompletedThis study tested whether taking a probiotic called Lactobacillus reuteri could reduce the number of repeat urinary tract infections (UTIs) in adult women who had recently finished antibiotic treatment for a UTI. 140 women with a history of recurrent UTIs took either the probioti…
Sponsor: BioGaia AB • Aim: Disease control
Last updated Jun 26, 2026 17:07 UTC
-
Probiotic shows promise for soothing colicky infants
Symptom relief CompletedThis study tested whether a probiotic called L. reuteri can reduce crying and fussing in babies with colic. Fifty infants aged 3-12 weeks, who were mostly breastfed, took either the probiotic or a placebo for 7 days. The main goal was to see if the probiotic helped decrease daily…
Sponsor: BioGaia AB • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC